Tissue factor activity in women with preeclampsia or SGA: a potential explanation for the excessive thrombin generation in these syndromes

References

• White CG II, Marder VJ, Schulman S, et al., editors. Overview of basic coagulation and fibrinolysis. In: Thrombosis and hemostasis. 6th ed. Philadelphia, PA: Lippencott Williams & Wilkins; 2013. p. 103–110.
   Google Scholar
• Broze GJ Jr, Girard TJ, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry. 1990;29:7539–7546.
   PubMed Web of Science ®Google Scholar
• Broze GJ Jr, Warren LA, Novotny WF, et al. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. Blood. 1988;71:335–343.
   PubMed Web of Science ®Google Scholar
• Osterud B. Tissue factor expression by monocytes: regulation and pathophysiological roles. Blood Coagul Fibrinolysis. 1998;9:S9–S14.
   PubMed Web of Science ®Google Scholar
• Osterud B, Bjorklid E. Sources of tissue factor. Semin Thromb Hemost. 2006;32:11–23.
   PubMed Web of Science ®Google Scholar
• Schouten M, Wiersinga WJ, Levi M, et al. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol. 2008;83:536–545.
   PubMed Web of Science ®Google Scholar
• Gando S, Kameue T, Nanzaki S, et al. Participation of tissue factor and thrombin in posttraumatic systemic inflammatory syndrome. Crit Care Med. 1997;25:1820–1826.
   PubMed Web of Science ®Google Scholar
• Green J, Doughty L, Kaplan SS, et al. The tissue factor and plasminogen activator inhibitor type-1 response in pediatric sepsis-induced multiple organ failure. Thromb Haemost. 2002;87:218–223.
   PubMed Web of Science ®Google Scholar
• Lockwood CJ, Krikun G, Rahman M, et al. The role of decidualization in regulating endometrial hemostasis during the menstrual cycle, gestation, and in pathological states. Semin Thromb Hemost. 2007;33:111–117.
   PubMed Web of Science ®Google Scholar
• Dusse LM, Carvalho MG, Cooper AJ, et al. Tissue factor and tissue factor pathway inhibitor: a potential role in pregnancy and obstetric vascular complications? Clin Chim Acta. 2006;372:43–46.
   PubMed Web of Science ®Google Scholar
• Ruf W, Mueller BM. Tissue factor in cancer angiogenesis and metastasis. Curr Opin Hematol. 1996;3:379–384.
   PubMedGoogle Scholar
• Wojtukiewicz MZ, Sierko E, Klement P, et al. The hemostatic system and angiogenesis in malignancy. Neoplasia. 2001;3:371–384.
   PubMed Web of Science ®Google Scholar
• Nash GF, Walsh DC, Kakkar AK. The role of the coagulation system in tumour angiogenesis. Lancet Oncol. 2001;2:608–613.
   PubMed Web of Science ®Google Scholar
• Brodsky SV. Coagulation, fibrinolysis and angiogenesis: new insights from knockout mice. Exp Nephrol. 2002;10:299–306.
   PubMedGoogle Scholar
• Schatz F, Krikun G, Caze R, et al. Progestin-regulated expression of tissue factor in decidual cells: implications in endometrial hemostasis, menstruation and angiogenesis. Steroids. 2003;68:849–860.
   PubMed Web of Science ®Google Scholar
• Belting M, Ahamed J, Ruf W. Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arterioscler Thromb Vascular Biol. 2005;25:1545–1550.
   PubMed Web of Science ®Google Scholar
• Hahn L. On fibrinolysis and coagulation during parturition and menstruation. Acta Obstet Gynecol Scand Suppl. 1974;28:7–40.
   PubMedGoogle Scholar
• Holmes VA, Wallace JM. Haemostasi in normal pregnancy: a balancing act? Biochem SocTrans. 2005;33:428–432.
   PubMed Web of Science ®Google Scholar
• Erez O, Romero R, Vaisbuch E, et al. High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor. J Matern Fetal Neonatal Med. 2010;23:23–33.
   PubMed Web of Science ®Google Scholar
• Uszynski M, Zekanowska E, Uszynski W, Kuczynski J. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism. Eur J Obstet Gynecol Reprod Biol. 2001;95:163–166.
   PubMed Web of Science ®Google Scholar
• Erez O, Gotsch F, Mazaki-Tovi S, et al. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death. J Matern Fetal Neonatal Med. 2009;22:672–687.
   PubMed Web of Science ®Google Scholar
• Rousseau A, Favier R, Van Dreden P. Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: new and useful markers for pre-eclampsia? Eur J Obstetr Gynecol Reprod Biol. 2009;146:46–49.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Espinoza J, Yoshimatsu J, et al. Activation of coagulation system in preterm labor and preterm premature rupture of membranes. J Matern Fetal Neonatal Med. 2002;11:368–373.
   PubMedGoogle Scholar
• Chaiworapongsa T, Yoshimatsu J, Espinoza J, et al. Evidence of in vivo generation of thrombin in patients with small-for-gestational-age fetuses and pre-eclampsia. J Matern Fetal Neonatal Med. 2002;11:362–367.
   PubMedGoogle Scholar
• Erez O, Espinoza J, Chaiworapongsa T, et al. A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor. J Matern Fetal Neonatal Med. 2008;21:732–744.
   PubMed Web of Science ®Google Scholar
• Erez O, Romero R, Hoppensteadt D, et al. Tissue factor and its natural inhibitor in pre-eclampsia and SGA. J Matern Fetal Neonatal Med. 2008;21:855–869.
   PubMed Web of Science ®Google Scholar
• Bellart J, Gilabert R, Angles A, et al. Tissue factor levels and high ratio of fibrinopeptide A:D-dimer as a measure of endothelial procoagulant disorder in pre-eclampsia. Br J Obstet Gynaecol. 1999;106:594–597.
   PubMedGoogle Scholar
• Schjetlein R, Abdelnoor M, Haugen G, et al. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia. Acta Obstet Gynecol Scand. 1999;78:191–197.
   PubMed Web of Science ®Google Scholar
• Erez O, Hoppensteadt D, Romero R, et al. Preeclampsia is associated with low concentrations of protein Z. J Matern Fetal Neonatal Med. 2007;20:661–667.
   PubMed Web of Science ®Google Scholar
• Kusanovic JP, Espinoza J, Romero R, et al. Plasma protein Z concentrations in pregnant women with idiopathic intrauterine bleeding and in women with spontaneous preterm labor. J Matern Fetal Neonatal Med. 2007;20:453–463.
   PubMed Web of Science ®Google Scholar
• Cadroy Y, Grandjean H, Pichon J, et al. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obstet Gynaecol. 1993;100:416–420.
   PubMedGoogle Scholar
• de Boer K, ten Cate JW, Sturk A, et al. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol. 1989;160:95–100.
   PubMed Web of Science ®Google Scholar
• Higgins JR, Walshe JJ, Darling MR, et al. Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies. Am J Obstet Gynecol. 1998;179:520–526.
   PubMed Web of Science ®Google Scholar
• ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol. 2002;99:159–167.
   PubMed Web of Science ®Google Scholar
• Alexander GR, Himes JH, Kaufman RB, et al. A United States national reference for fetal growth. Obstet Gynecol. 1996;87:163–168.
   PubMed Web of Science ®Google Scholar
• Redline RW, Heller D, Keating S, Kingdom J. Placental diagnostic criteria and clinical correlation – a workshop report. Placenta. 2005;26:S114–S117.
   PubMed Web of Science ®Google Scholar
• Lockwood CJ, Krikun G, Schatz F. The decidua regulates hemostasis in human endometrium. Semin Reprod Endocrinol. 1999;17:45–51.
   PubMedGoogle Scholar
• Lockwood CJ, Krikun G, Caze R, et al. Decidual cell-expressed tissue factor in human pregnancy and its involvement in hemostasis and preeclampsia-related angiogenesis. Ann NY Acad Sci 2008;1127:67–72.
   PubMed Web of Science ®Google Scholar
• Erez O, Hoppensteadt D, Than NG, et al. Tissue factor and its natural inhibitor in preeclampsia and SGA. Reprod Sci. 2007;14:182A.
   PubMed Web of Science ®Google Scholar
• Elovitz MA, Baron J, Phillippe M. The role of thrombin in preterm parturition. Am J Obstet Gynecol. 2001;185:1059–1063.
   PubMed Web of Science ®Google Scholar
• Butenas S, Bouchard BA, Brummel-Ziedins KE, et al. Tissue factor activity in whole blood. Blood. 2005;105:2764–2770.
   PubMed Web of Science ®Google Scholar
• Balasubramanian V, Grabowski E, Bini A, Nemerson Y. Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions. Blood. 2002;100:2787–2792.
   PubMed Web of Science ®Google Scholar
• Balasubramanian V, Vele O, Nemerson Y. Local shear conditions and platelet aggregates regulate the incorporation and activity of circulating tissue factor in ex-vivo thrombi. Thromb Haemost. 2002;88:822–826.
   PubMed Web of Science ®Google Scholar
• Chou J, Mackman N, Merrill-Skoloff G, et al. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood. 2004;104:3190–3197.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Wada H, Wakita Y, et al. Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura. Thromb Haemost. 1995;73:10–14.
   PubMed Web of Science ®Google Scholar
• Osterud B. Cellular interactions in tissue factor expression by blood monocytes. Blood Coagul Fibrinolysis. 1995;6(Suppl 1):S20–S25.
   PubMed Web of Science ®Google Scholar
• Gervasi MT, Chaiworapongsa T, Naccasha N, et al. Phenotypic and metabolic characteristics of maternal monocytes and granulocytes in preterm labor with intact membranes. Am J Obstet Gynecol. 2001;185:1124–1129.
   PubMed Web of Science ®Google Scholar
• Carr DB, McDonald GB, Brateng D, et al. The relationship between hemodynamics and inflammatory activation in women at risk for preeclampsia. Obstetr Gynecol. 2001;98:1109–1116.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. The pathogenesis of pre-eclampsia. Gynecol Obstet Fertil. 2001;29:518–522.
   PubMedGoogle Scholar
• Chaiworapongsa T, Gervasi MT, Refuerzo J, et al. Maternal lymphocyte subpopulations (CD45RA + and CD45RO+) in preeclampsia. Am J Obstet Gynecol. 2002;187:889–893.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response – a review. Placenta. 2003;24:S21–S27.
   PubMed Web of Science ®Google Scholar
• Sargent IL, Germain SJ, Sacks GP, et al. Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. J Reprod Immunol. 2003;59:153–160.
   PubMed Web of Science ®Google Scholar
• Borzychowski AM, Sargent IL, Redman CW. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med. 2006;11:309–316.
   PubMed Web of Science ®Google Scholar
• Saito S, Sakai M. Th1/Th2 balance in preeclampsia. J Reprod Immunol. 2003;59:161–173.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180(2 Pt 1):499–506.
   PubMed Web of Science ®Google Scholar
• Bailey K, Herrod HG, Younger R, Shaver D. Functional aspects of T-lymphocyte subsets in pregnancy. Obstetr Gynecol. 1985;66:211–215.
   PubMed Web of Science ®Google Scholar
• Haeger M, Unander M, Norder-Hansson B, et al. Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstetr Gynecol. 1992;79:19–26.
   PubMed Web of Science ®Google Scholar
• Daniel Y, Kupferminc MJ, Baram A, et al. Plasma interleukin-12 is elevated in patients with preeclampsia. Am J Reprod Immunol. 1998;39:376–380.
   PubMed Web of Science ®Google Scholar
• Gervasi MT, Chaiworapongsa T, Pacora P, et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol. 2001;185:792–797.
   PubMed Web of Science ®Google Scholar
• Mellembakken JR, Aukrust P, Olafsen MK, et al. Activation of leukocytes during the uteroplacental passage in preeclampsia. Hypertension. 2002;39:155–160.
   PubMed Web of Science ®Google Scholar
• Sakai M, Tsuda H, Tanebe K, et al. Interleukin-12 secretion by peripheral blood mononuclear cells is decreased in normal pregnant subjects and increased in preeclamptic patients. Am J Reprod Immunol. 2002;47:91–97.
   PubMed Web of Science ®Google Scholar
• Holthe MR, Lyberg T, Staff AC, Berge LN. Leukocyte-platelet interaction in pregnancies complicated with preeclampsia. Platelets. 2005;16:91–97.
   PubMed Web of Science ®Google Scholar
• Schiessl B. Inflammatory response in preeclampsia. Mol Aspects Med. 2007;28:210–219.
   PubMed Web of Science ®Google Scholar
• Saito S, Shiozaki A, Nakashima A, et al. The role of the immune system in preeclampsia. Mol Aspects Med. 2007;28:192–209.
   PubMed Web of Science ®Google Scholar
• Ogge G, Romero R, Chaiworapongsa T, et al. Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia. J Matern Fetal Neonatal Med. 2010;23:476–487.
   PubMed Web of Science ®Google Scholar
• Satta N, Toti F, Feugeas O, et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol. 1994;153:3245–3255.
   PubMed Web of Science ®Google Scholar
• Osterud B. The role of platelets in decrypting monocyte tissue factor. Semin Hematol. 2001;38(4 Suppl 12):2–5.
   PubMed Web of Science ®Google Scholar
• Sabatier F, Roux V, Anfosso F, et al. Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood. 2002;99:3962–3970.
   PubMed Web of Science ®Google Scholar
• Shet AS, Aras O, Gupta K, et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood. 2003;102:2678–2683.
   PubMed Web of Science ®Google Scholar
• Eilertsen KE, Osterud B. The role of blood cells and their microparticles in blood coagulation. Biochem Soc Trans. 2005;33(Pt 2):418–422.
   PubMed Web of Science ®Google Scholar
• Baroni M, Pizzirani C, Pinotti M, et al. Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. FASEB J. 2007;21:1926–1933.
   PubMed Web of Science ®Google Scholar
• Poitevin S, Cochery-Nouvellon E, Dupont A, Nguyen P. Monocyte IL-10 produced in response to lipopolysaccharide modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles. Thromb Haemost. 2007;97:598–607.
   PubMed Web of Science ®Google Scholar
• Bach RR, Moldow CF. Mechanism of tissue factor activation on HL-60 cells. Blood. 1997;89:3270–3276.
   PubMed Web of Science ®Google Scholar
• Butenas S, Mann KG. Blood coagulation. Biochemistry (Mosc). 2002;67:3–12.
   PubMed Web of Science ®Google Scholar
• Egorina EM, Sovershaev MA, Bjorkoy G, et al. Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability. Arterioscler Thromb Vasc Biol. 2005;25:1493–1498.
   PubMed Web of Science ®Google Scholar
• Rivers RP, Hathaway WE, Weston WL. The endotoxin-induced coagulant activity of human monocytes. Br J Haematol. 1975;30:311–316.
   PubMed Web of Science ®Google Scholar
• Chen Y, Huang Y, Jiang R, Teng Y. Syncytiotrophoblast-derived microparticle shedding in early-onset and late-onset severe pre-eclampsia. Int J Gynaecol Obstet. 2012;119:234–238.
   PubMed Web of Science ®Google Scholar
• Guller S, Ma YY, Fu HH, et al. The placental syncytium and the pathophysiology of preeclampsia and intrauterine growth restriction: a novel assay to assess syncytial protein expression. Ann NY Acad Sci. 2008;1127:129–133.
   PubMed Web of Science ®Google Scholar
• Marques FK, Campos FM, Sousa LP, et al. Association of microparticles and preeclampsia. Mol Biol Rep. 2013;40:4553–4559.
   PubMed Web of Science ®Google Scholar
• Orozco AF, Jorgez CJ, Ramos-Perez WD, et al. Placental release of distinct DNA-associated micro-particles into maternal circulation: reflective of gestation time and preeclampsia. Placenta. 2009;30:891–897.
   Google Scholar
• Petrozella L, Mahendroo M, Timmons B, et al. Endothelial microparticles and the antiangiogenic state in preeclampsia and the postpartum period. Am J Obstet Gynecol. 2012;207:140–146.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Microparticles and immunomodulation in pregnancy and pre-eclampsia. J Reprod Immunol. 2007;76:61–67.
   PubMed Web of Science ®Google Scholar
• Langbein M, Strick R, Strissel PL, et al. Impaired cytotrophoblast cell-cell fusion is associated with reduced Syncytin and increased apoptosis in patients with placental dysfunction. Mol Reprod Dev. 2008;75:175–183.
   PubMed Web of Science ®Google Scholar
• Reddy A, Zhong XY, Rusterholz C, et al. The effect of labour and placental separation on the shedding of syncytiotrophoblast microparticles, cell-free DNA and mRNA in normal pregnancy and pre-eclampsia. Placenta. 2008;29:942–949.
   Google Scholar
• Butenas S, Krudysz-Amblo J, Mann KG. Posttranslational modifications and activity of natural and recombinant tissue factor. Thromb Res. 2010;125(Suppl 1):S26–S28.
   PubMed Web of Science ®Google Scholar
• Gardiner C, Tannetta DS, Simms CA, et al. Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity. PLoS One. 2011;6:e26313.
   PubMed Web of Science ®Google Scholar
• VanWijk MJ, Boer K, Berckmans RJ, et al. Enhanced coagulation activation in preeclampsia: the role of APC resistance, microparticles and other plasma constituents. Thromb Haemost. 2002;88:415–420.
   PubMed Web of Science ®Google Scholar
• Erez O, Romero R, Vaisbuch E, Kusanovic JP, Mazaki-Tovi S, Gotsch F, et al. The pattern and magnitude of in-vivo thrombin generation is different in women with preeclampsia and in those with SGA fetuses without preeclampsia. Reprod Sci. 2009;16:170A.
   Web of Science ®Google Scholar